Friday, 10 Oct 2025
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA
logo logo
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
  • đŸ”„
  • Trump
  • VIDEO
  • House
  • White
  • ScienceAlert
  • Trumps
  • Watch
  • man
  • Health
  • Season
Font ResizerAa
American FocusAmerican Focus
Search
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
Follow US
© 2024 americanfocus.online – All Rights Reserved.
American Focus > Blog > Health and Wellness > New Vaccine Shows Promise For Kidney Cancer
Health and Wellness

New Vaccine Shows Promise For Kidney Cancer

Last updated: February 6, 2025 12:34 am
Share
New Vaccine Shows Promise For Kidney Cancer
SHARE

New Cancer Vaccine Shows Promise in Treating Kidney Cancer

A groundbreaking treatment approach for kidney cancer has demonstrated significant success in a phase I clinical trial, offering hope for patients battling this challenging disease.

Recently published in Nature, the results of a trial conducted at Dana-Farber Cancer Institute in Boston, MA have revealed that all nine patients who received the personalized immunotherapy treatment, known as a cancer vaccine, remain cancer-free three years post-treatment.

Unlike traditional vaccines that prevent infectious diseases, cancer vaccines are designed to stimulate the immune system to target and destroy cancer cells in individuals already diagnosed with cancer. While previous cancer vaccines have shown promise in various tumor types, this trial marks a significant breakthrough in the treatment of kidney cancer, a disease known for its high recurrence rate and challenging nature.

In this particular trial, patients underwent surgery to remove the bulk of their tumors, after which samples were analyzed to create a personalized cancer vaccine targeting neoantigens, specific characteristics of the tumor that can trigger an immune response. The vaccine was then administered to help the immune system identify and eliminate any remaining cancer cells.

Dr. David A. Braun, the lead author of the study, emphasized the unique approach of this vaccine, stating, “We pick targets that are unique to the cancer and different from any normal part of the body, so the immune system can be effectively ‘steered’ towards the cancer in a very specific way.” The long-lasting immune responses generated by this treatment hold promise for preventing tumor recurrence.

While the trial’s sample size is small, the fact that all patients remained cancer-free three years after treatment is a positive indicator, especially for individuals with advanced kidney cancer at high risk of recurrence. Unlike traditional chemotherapy, which may only provide temporary benefits, immunotherapies like cancer vaccines train the immune system to recognize and attack tumor cells long-term, reducing the likelihood of cancer resurgence.

See also  22 pesticides show links to prostate cancer

Moreover, the absence of significant side effects reported in the trial is another encouraging aspect of this treatment approach. Dr. Braun believes that this research lays the groundwork for further development of neoantigen vaccines in kidney cancer, paving the way for improved outcomes and reduced side effects in the future.

TAGGED:cancerkidneypromiseShowsvaccine
Share This Article
Twitter Email Copy Link Print
Previous Article California community is sliding toward the Pacific Ocean California community is sliding toward the Pacific Ocean
Next Article Brute accused of killing NYC dad with random knockout punch charged with manslaughter: cops Brute accused of killing NYC dad with random knockout punch charged with manslaughter: cops
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular Posts

Ariana DeBose Won’t Star in ‘Evita’ in London ‘Due to Scheduling’

Ariana DeBose, the Oscar-winning actress, will not be taking on the role of Eva PerĂłn…

January 29, 2025

AstraZeneca unveils $50 billion US investment as pharma tariff threat looms

AstraZeneca Announces $50 Billion Investment in U.S. Manufacturing and Research By Ahmed Aboulenein and Maggie…

July 23, 2025

JS Mobility: Slate’s ‘transformer’ EV truck breaks cover and Tesla’s dueling realities

Welcome to JS Mobility! Hey there, welcome back to JS Mobility, your go-to source for…

April 25, 2025

Why the dire wolf de-extinction claims are the tip of the iceberg

Colossal Biosciences Successfully Revives Extinct Dire Wolf Colossal Biosciences says it has revived the dire…

April 17, 2025

Morris Chestnut Talks ‘Watson’ and Reclaiming Iconic Characters

Morris Chestnut, known for his role in the TV series "Watson," drew inspiration from reading…

June 14, 2025

You Might Also Like

President Trump is in ‘exceptional health,’ his doctor says, after visit to Walter Reed
Health and Wellness

President Trump is in ‘exceptional health,’ his doctor says, after visit to Walter Reed

October 10, 2025

Trump Shows Signs Of Full-Blown Mental Collapse At White House Event

October 10, 2025
In a First, Pig Liver Helped a Cancer Patient Survive for More Than a Month
Tech and Science

In a First, Pig Liver Helped a Cancer Patient Survive for More Than a Month

October 10, 2025
Presidential Message on National Breast Cancer Awareness Month
The White House

Presidential Message on National Breast Cancer Awareness Month

October 10, 2025
logo logo
Facebook Twitter Youtube

About US


Explore global affairs, political insights, and linguistic origins. Stay informed with our comprehensive coverage of world news, politics, and Lifestyle.

Top Categories
  • Crime
  • Environment
  • Sports
  • Tech and Science
Usefull Links
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA

© 2024 americanfocus.online –  All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?